QIAGEN Revenue 2006-2019 | QGEN

QIAGEN annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • QIAGEN revenue for the quarter ending June 30, 2019 was $0.382B, a 1.17% increase year-over-year.
  • QIAGEN revenue for the twelve months ending June 30, 2019 was $1.511B, a 2.01% increase year-over-year.
  • QIAGEN annual revenue for 2018 was $1.502B, a 5.95% increase from 2017.
  • QIAGEN annual revenue for 2017 was $1.418B, a 5.95% increase from 2016.
  • QIAGEN annual revenue for 2016 was $1.338B, a 4.45% increase from 2015.
QIAGEN Annual Revenue
(Millions of US $)
2018 $1,502
2017 $1,418
2016 $1,338
2015 $1,281
2014 $1,345
2013 $1,302
2012 $1,254
2011 $1,170
2010 $1,087
2009 $1,010
2008 $893
2007 $650
2006 $466
2005 $398
QIAGEN Quarterly Revenue
(Millions of US $)
Q2 2019 $382
Q1 2019 $349
Q4 2018 $403
Q3 2018 $378
Q2 2018 $377
Q1 2018 $344
Q4 2017 $397
Q3 2017 $364
Q2 2017 $349
Q1 2017 $308
Q4 2016 $367
Q3 2016 $339
Q2 2016 $334
Q1 2016 $298
Q4 2015 $349
Q3 2015 $315
Q2 2015 $319
Q1 2015 $298
Q4 2014 $360
Q3 2014 $336
Q2 2014 $331
Q1 2014 $317
Q4 2013 $361
Q3 2013 $322
Q2 2013 $315
Q1 2013 $304
Q4 2012 $347
Q3 2012 $304
Q2 2012 $307
Q1 2012 $296
Q4 2011 $334
Q3 2011 $289
Q2 2011 $282
Q1 2011 $264
Q4 2010 $286
Q3 2010 $274
Q2 2010 $263
Q1 2010 $264
Q4 2009 $289
Q3 2009 $260
Q2 2009 $240
Q1 2009 $221
Q4 2008 $237
Q3 2008 $231
Q2 2008 $218
Q1 2008 $207
Q4 2007 $210
Q3 2007 $177
Q2 2007 $135
Q1 2007 $128
Q4 2006 $126
Q3 2006 $118
Q2 2006 $113
Q1 2006 $109
Q4 2005 $104
Q3 2005 $99
Q2 2005 $100
Q1 2005 $95
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.850B $1.502B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.538B 14.07
Gilead Sciences (GILD) United States $81.192B 9.97
Celgene (CELG) United States $67.486B 10.44
Vertex Pharmaceuticals (VRTX) United States $48.089B 51.97
Biogen (BIIB) United States $43.478B 7.72
Illumina (ILMN) United States $42.432B 49.85
CSL (CSLLY) Australia $35.201B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.771B 14.87
Alexion Pharmaceuticals (ALXN) United States $25.266B 13.32
Incyte (INCY) United States $18.177B 53.49
Exact Sciences (EXAS) United States $15.300B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.892B 0.00
Seattle Genetics (SGEN) United States $12.839B 0.00
Genmab (GNMSF) Denmark $12.462B 63.35
Bio-Rad Laboratories (BIO.B) United States $9.886B 52.99
Guardant Health (GH) United States $9.236B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.141B 0.00
Sarepta Therapeutics (SRPT) United States $8.944B 0.00
Galapagos (GLPG) Belgium $8.582B 0.00
Bio-Techne Corp (TECH) United States $7.344B 50.76
BeiGene (BGNE) Cayman Islands $7.041B 0.00
Exelixis (EXEL) United States $6.861B 17.83
Bluebird Bio (BLUE) United States $6.746B 0.00
Amarin (AMRN) Ireland $5.594B 0.00
Horizon Pharma Public (HZNP) Ireland $5.127B 13.03
Ascendis Pharma (ASND) Denmark $4.875B 0.00
Repligen (RGEN) United States $4.823B 93.60
Moderna (MRNA) United States $4.424B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.419B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.225B 0.00
Blueprint Medicines (BPMC) United States $3.992B 0.00
China Biologic Products (CBPO) China $3.912B 24.42
Spark Therapeutics (ONCE) United States $3.888B 0.00
MorphoSys AG (MOR) Germany $3.874B 0.00
Mirati Therapeutics (MRTX) United States $3.624B 0.00
Alkermes (ALKS) Ireland $3.469B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.426B 0.00
Immunomedics (IMMU) United States $2.849B 0.00
Arena Pharmaceuticals (ARNA) United States $2.822B 6.06
Genomic Health (GHDX) United States $2.768B 51.90
Amicus Therapeutics (FOLD) United States $2.676B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.656B 0.00
NeoGenomics (NEO) United States $2.649B 141.72
Medicines (MDCO) United States $2.633B 0.00
MyoKardia (MYOK) United States $2.536B 0.00
Acceleron Pharma (XLRN) United States $2.450B 0.00
Halozyme Therapeutics (HALO) United States $2.440B 0.00
Reata Pharmaceuticals (RETA) United States $2.358B 0.00
Emergent Biosolutions (EBS) United States $2.279B 34.23
Intercept Pharmaceuticals (ICPT) United States $2.165B 0.00
UniQure (QURE) Netherlands $2.152B 0.00
Akcea Therapeutics (AKCA) United States $2.042B 0.00
Cambrex (CBM) United States $1.993B 25.20
Zai Lab (ZLAB) China $1.976B 0.00
Myriad Genetics (MYGN) United States $1.853B 19.44
Ligand Pharmaceuticals (LGND) United States $1.846B 23.34
Denali Therapeutics (DNLI) United States $1.803B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.621B 0.00
Insmed (INSM) United States $1.506B 0.00
REGENXBIO (RGNX) United States $1.382B 0.00
Coherus BioSciences (CHRS) United States $1.375B 0.00
RA PHARMCTL INC (RARX) United States $1.362B 0.00
Sangamo Therapeutics (SGMO) United States $1.342B 0.00
AnaptysBio (ANAB) United States $1.321B 0.00
Editas Medicine (EDIT) United States $1.277B 0.00
Epizyme (EPZM) United States $1.262B 0.00
Fate Therapeutics (FATE) United States $1.242B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.227B 0.00
Athenex (ATNX) United States $1.214B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.204B 0.00
Innoviva (INVA) United States $1.173B 3.39
Alector (ALEC) United States $1.083B 0.00
Zymeworks (ZYME) Canada $0.989B 0.00
Twist Bioscience (TWST) United States $0.988B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.980B 0.00
Cara Therapeutics (CARA) United States $0.945B 0.00
Principia Biopharma (PRNB) United States $0.941B 490.63
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
Intellia Therapeutics (NTLA) United States $0.847B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.842B 0.00
Adverum Biotechnologies (ADVM) United States $0.833B 0.00
Cytokineticsorporated (CYTK) United States $0.821B 0.00
ANI Pharmaceuticals (ANIP) United States $0.817B 13.64
Vanda Pharmaceuticals (VNDA) United States $0.817B 29.48
Alder BioPharmaceuticals (ALDR) United States $0.813B 0.00
Arvinas (ARVN) United States $0.807B 0.00
Anika Therapeutics (ANIK) United States $0.792B 28.03
Codexis (CDXS) United States $0.769B 0.00
Retrophin (RTRX) United States $0.762B 0.00
Pharming Group (PHGUF) Netherlands $0.759B 0.00
Vericel (VCEL) United States $0.757B 0.00
WAVE Life Sciences (WVE) Singapore $0.745B 0.00
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Stemline Therapeutics (STML) United States $0.663B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.650B 0.00
Zealand Pharma (ZEAL) Denmark $0.640B 7.42
MiMedx (MDXG) United States $0.611B 0.00
Heska (HSKA) United States $0.576B 74.64
DBV Technologies S.A (DBVT) France $0.552B 0.00
Cellectis S.A (CLLS) France $0.537B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.516B 0.00
Revance Therapeutics (RVNC) United States $0.503B 0.00
Intra-Cellular Therapies (ITCI) United States $0.501B 0.00
PHARMA MAR SA (PHMMF) Spain $0.501B 0.00
Precision BioSciences (DTIL) United States $0.494B 0.00
Syros Pharmaceuticals (SYRS) United States $0.474B 0.00
Mesoblast (MESO) Australia $0.470B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.459B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.436B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.434B 0.00
CytomX Therapeutics (CTMX) United States $0.434B 0.00
Merus (MRUS) Netherlands $0.422B 0.00
BioDelivery Sciences (BDSI) United States $0.398B 0.00
Puma Biotechnology (PBYI) United States $0.397B 0.00
Agenus (AGEN) United States $0.390B 0.00
AC Immune SA (ACIU) Switzerland $0.387B 28.65
AMAG Pharmaceuticals (AMAG) United States $0.379B 0.00
Avid Bioservices (CDMO) United States $0.374B 0.00
Gritstone Oncology (GRTS) United States $0.352B 0.00
Scholar Rock Holding (SRRK) United States $0.343B 0.00
Kadmon Holdings (KDMN) United States $0.333B 0.00
Arcus Biosciences (RCUS) United States $0.331B 0.00
Clovis Oncology (CLVS) United States $0.325B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Albireo Pharma (ALBO) United States $0.318B 0.00
Theratechnologies (THERF) Canada $0.316B 0.00
Prothena (PRTA) Ireland $0.315B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
Cel-Sci (CVM) United States $0.302B 0.00
Sorrento Therapeutics (SRNE) United States $0.301B 0.00
Protagonist Therapeutics (PTGX) United States $0.290B 0.00
Kindred Biosciences (KIN) United States $0.289B 0.00
PDL BioPharma (PDLI) United States $0.286B 7.35
Dynavax Technologies (DVAX) United States $0.282B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.274B 0.00
Geron (GERN) United States $0.266B 0.00
Senesco Technologies (ELOX) United States $0.250B 0.00
ADMA Biologics Inc (ADMA) United States $0.243B 0.00
Cellular Biomedicine (CBMG) United States $0.241B 0.00
Inovio Pharmaceuticals (INO) United States $0.241B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.237B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.234B 0.00
Seres Therapeutics (MCRB) United States $0.231B 0.00
Prometic Life Sciences (PFSCF) Canada $0.230B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.229B 0.00
ChromaDex (CDXC) United States $0.223B 0.00
MannKind (MNKD) United States $0.222B 0.00
Pfenex (PFNX) United States $0.222B 0.00
Five Prime Therapeutics (FPRX) United States $0.216B 0.00
Kamada (KMDA) Israel $0.216B 8.26
PHASEBIO PHARMA (PHAS) United States $0.215B 0.00
Athersys (ATHX) United States $0.205B 0.00
Sutro Biopharma (STRO) United States $0.203B 0.00
Compugen (CGEN) Israel $0.200B 0.00
CorMedix Inc (CRMD) United States $0.199B 0.00
Palatin Technologies (PTN) United States $0.195B 0.00
Cue Biopharma (CUE) United States $0.187B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.183B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
Dyadic (DYAI) United States $0.179B 0.00
Affimed (AFMD) Germany $0.177B 0.00
Novavax (NVAX) United States $0.174B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
POXEL SA FRANCE (PXXLF) $0.163B 0.00
Arsanis (XFOR) United States $0.161B 0.00
Emmaus Life Sciences (EMMA) United States $0.161B 0.00
Cerecor (CERC) United States $0.160B 0.00
OSMOTICA PHARM (OSMT) United States $0.159B 0.00
Alcobra (ARCT) United States $0.158B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.156B 0.00
XOMA (XOMA) United States $0.155B 0.00
Synlogic (SYBX) United States $0.153B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.150B 0.00
BioTime (LCTX) United States $0.150B 9.99
Strongbridge Biopharma (SBBP) United States $0.149B 6.11
Enzo Biochem (ENZ) United States $0.148B 0.00
Nicox SA (NICXF) France $0.147B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.144B 0.00
Acorda Therapeutics (ACOR) United States $0.141B 0.00
Adocia (ADOCY) France $0.140B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.125B 0.00
NantKwest (NK) United States $0.124B 0.00
Celyad SA (CYAD) Belgium $0.123B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.118B 0.00
Fortress Biotech (FBIO) United States $0.116B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Northwest Biotherapeutics (NWBO) United States $0.115B 0.00
TOCAGEN INC (TOCA) United States $0.113B 0.00
Abeona Therapeutics (ABEO) United States $0.110B 0.00
Aduro Biotech (ADRO) United States $0.110B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.109B 0.00
Checkpoint Therapeutics (CKPT) United States $0.107B 0.00
Liquidia Technologies (LQDA) United States $0.105B 0.00
Aptinyx (APTX) United States $0.104B 0.00
OvaScience (MLND) United States $0.098B 0.00
Verastem (VSTM) United States $0.096B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Menlo Therapeutics (MNLO) United States $0.091B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.087B 0.00
Trevena (TRVN) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.074B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Antibe Therapeutics (ATBPF) Canada $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
ARAVIVE, INC (ARAV) United States $0.070B 0.00
VTv Therapeutics (VTVT) United States $0.070B 0.00
Curis (CRIS) United States $0.068B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.066B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
VBI Vaccines (VBIV) United States $0.064B 0.00
Unum Therapeutics (UMRX) United States $0.064B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Applied Genetic Technologies (AGTC) United States $0.058B 31.80
Prima BioMed (IMMP) Australia $0.058B 0.00
Oncobiologics (OTLK) United States $0.055B 0.00
AIT Therapeutics (XAIR) United States $0.054B 0.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
Ophthotech (ISEE) United States $0.049B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Signal Genetics (MGEN) United States $0.042B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
Protalix BioTherapeutics (PLX) Israel $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.037B 0.00
Aptevo Therapeutics (APVO) United States $0.037B 0.00
VIVUS (VVUS) United States $0.036B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
Proteostasis Therapeutics (PTI) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.032B 0.00
Entera Bio (ENTX) Israel $0.031B 0.21
DiaMedica Therapeutics (DMAC) United States $0.029B 0.00
VistaGen Therapeutics (VTGN) United States $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
Soligenix (SNGX) United States $0.021B 0.00
Vical (VICL) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.27
Bionano Genomics (BNGO) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Novogen (KZIA) Australia $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
CollPlant Holdings (CLGN) Israel $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
AmpliPhi Biosciences (ARMP) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
BioPharmX (BPMX) United States $0.003B 0.00
Neuralstem (CUR) United States $0.002B 0.00